High dose interleukin-2 (IL-2) is active against metastatic melanoma and renal cell carcinoma, but treatment-associated toxicity and expansion of supp......
Sharma, M; Khong, H; Fa'ak, F; Bentebibel, SE; Janssen, LME; Chesson, BC; Creasy, CA; Forget, MA; Kahn, LMS; Pazdrak, B; Karki, B; Hailemichael, Y; Singh, M; Vianden, C; Vennam, S; Bharadwaj, U; Tweardy, DJ; Haymaker, C; Bernatchez, C; Huang, SX; Rajapakshe, K; Coarfa, C; Hurwitz, ME; Sznol, M; Hwu, P; Hoch, U; Addepalli, M; Charych, DH; Zalevsky, J; Diab, A; Overwijk, WW
Overwijk, WW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA.; Overwijk, WW (corresponding author), Nektar Therapeut, 455 Mission Bay Blvd South, San Francisco, CA 94158 USA.; Overwijk, WW (corresponding author), Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA.; Overwijk, WW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.
NATURE COMMUNICATIONS, 2020; 11 (1):